Notably, the DEGs from the M-C contrast were enriched for biological processes important for NAFLD, such as “cholesterol homeostasis” (ABCA1, GRAMD1B, INSIG1, LDLR, MYLIP, PCSK9, SREBF2, TMEM97) and “lipid metabolic process” (ACSL3, ACSL4, FADS1, FADS2, INSIG1, LDLR, LIPE, NAAA, and SCD; Table 2 and Table S4). The gene discussed is FADS1; the disease is metabolic dysfunction-associated steatotic liver disease.